These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7097524)

  • 1. Pharmacokinetic profile of progabide, a new gamma-aminobutyric acid-mimetic drug, in rhesus monkey.
    Johno I; Ludwick BT; Levy RH
    J Pharm Sci; 1982 Jun; 71(6):633-6. PubMed ID: 7097524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of progabide and valproic acid following intraperitoneal administration in rhesus monkey.
    Johno I; Bialer M; Nickelson SA; Levy RH
    Epilepsia; 1984 Oct; 25(5):578-85. PubMed ID: 6434296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.
    Patel IH; Levy RH; Bauer TG
    Epilepsia; 1975 Dec; 16(5):705-16. PubMed ID: 816644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic properties of ethosuximide in monkeys. II. Chronic intravenous and oral administration.
    Patel IH; Levy RH
    Epilepsia; 1975 Dec; 16(5):717-30. PubMed ID: 816645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic profile of a new anticonvulsant, stiripentol, in the rhesus monkey.
    Lin HS; Levy RH
    Epilepsia; 1983 Dec; 24(6):692-703. PubMed ID: 6641646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
    Radulovic LL; Türck D; von Hodenberg A; Vollmer KO; McNally WP; DeHart PD; Hanson BJ; Bockbrader HN; Chang T
    Drug Metab Dispos; 1995 Apr; 23(4):441-8. PubMed ID: 7600909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progabide and SL 75102 binding to plasma proteins and red blood cells in humans.
    Hamberger C; Barre J; Brandebourger M; Urien S; Taiclet A; Thenot JP; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):178-84. PubMed ID: 3583466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic disposition of guanabenz in the rhesus monkey.
    Meacham RH; Chiang ST; Kick CJ; Sisenwine SF; Jusko WJ; Ruelius HW
    Drug Metab Dispos; 1981; 9(6):509-14. PubMed ID: 6120807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline absorption and disposition in rabbits: oral, intravenous, and concentration-dependent kinetic studies.
    El-Yazigi A; Sawchuk RJ
    J Pharm Sci; 1981 Apr; 70(4):452-6. PubMed ID: 7229966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
    Timchalk C; Nolan RJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of carbamazepine in monkeys following intravenous and oral administration.
    Levy RH; Lockard JS; Green JR; Friel P; Martis L
    J Pharm Sci; 1975 Feb; 64(2):302-7. PubMed ID: 1127587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of paraxanthine, one of the primary metabolites of caffeine, in the rat.
    Bortolotti A; Jiritano L; Bonati M
    Drug Metab Dispos; 1985; 13(2):227-31. PubMed ID: 2859173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of 6-mercaptopurine (6MP) in the monkey. I. Disposition from plasma and cerebrospinal fluid following iv bolus.
    Narang PK; Chatterji DC; O'Neill D; Poplack DG
    Drug Metab Dispos; 1983; 11(1):5-9. PubMed ID: 6132796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stability and solubility of progabide and its related metabolic derivatives.
    Farraj NF; Davis SS; Parr GD; Stevens HN
    Pharm Res; 1988 Apr; 5(4):226-31. PubMed ID: 3247302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey: estimate of percutaneous first-pass metabolism.
    Wester RC; Noonan PK; Smeach S; Kosobud L
    J Pharm Sci; 1983 Jul; 72(7):745-8. PubMed ID: 6411893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent kinetics of probenecid in rhesus monkeys-intravenous bolus studies.
    Chiang CW; Benet LZ
    Pharmacology; 1981; 23(6):326-36. PubMed ID: 7312942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of diazepam intramuscularly administered to rhesus monkeys.
    Lukey BJ; Corcoran KD; Solana RP
    J Pharm Sci; 1991 Oct; 80(10):918-21. PubMed ID: 1783998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic profile of (+/-)-gossypol in male Sprague-Dawley rats following single intravenous and oral and subchronic oral administration.
    Othman MA; Abou-Donia MB
    Proc Soc Exp Biol Med; 1988 May; 188(1):17-22. PubMed ID: 3368474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.
    Colletti AE; Krieter PA
    Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
    Siefert HM; Maruhn D; Maul W; Förster D; Ritter W
    Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.